July, 2021

  • 31 July

    OMERS Infrastructure Agrees to Purchase 19.4% Stake in Azure Power

    Transaction expands Canadian pension plan’s direct investment holdings in India, while increasing its global exposure to renewables sector SINGAPORE, July 30, 2021 (GLOBE NEWSWIRE) — OMERS Infrastructure today announced that it has signed a Stock Purchase Agreement to acquire from International Finance Corporation and IFC GIF Investment Company I an approximately 19.4% stake in Azure […]

    Read More »
  • 30 July

    RISULTATI DEL SECONDO TRIMESTRE 2021

    The following is an extract from the “CNH Industrial 2021 second quarter results” press release. The complete press release can be accessed by visiting the media section of the CNH Industrial corporate website: https://www.cnhindustrial.com/en-us/media/press_releases/Pages/default.aspx or consulting the accompanying PDF: CNH Industrial reports strong second quarter performance. Consolidated revenues of $8.9 billion (up 60% compared to […]

    Read More »
  • 30 July

    AKWEL: TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021

            Thursday 29 July 2021 TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021 AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, has posted consolidated turnover of €487.6m in the first half of 2021, up by 26.0% compared to the first half of the previous […]

    Read More »
  • 30 July

    Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted its supplemental New Drug Application (sNDA) for toripalimab in combination with platinum-containing chemotherapy […]

    Read More »
  • 30 July

    Fortinet Reports Second Quarter 2021 Financial Results

    Second Quarter 2021 Highlights Total revenue of $801.1 million, up 30% year over year Product revenue of $298.3 million, up 41% year over year Service revenue of $502.8 million, up 24% year over year Billings of $960.9 million, up 35% year over year1 Deferred revenue of $2.91 billion, up 27% year over year GAAP operating […]

    Read More »